FineHeart announces the appointment of Sébastien Robitaille as Chief Financial Officer
A seasoned expert to structure FineHeart’s key functions during its scale-up phase
Bordeaux, France, April 1, 2025 - FineHeart S.A., a clinical-stage medtech company developing breakthrough solutions for cardiology, announces the appointment of Sébastien Robitaille as Chief
Financial Officer. Driven by the challenges of scaling up innovative healthcare companies, Sébastien brings over 25 years
of professional experience, primarily in the pharmaceutical and biotechnology industries, with solidexpertise in business transformation and financing, including on the Nasdaq.